Facilitating Treatment Initiation in Early-Stage Alzheimer Disease
Webcast
0.5 AMA PRA Category 1 Credit™ OVERVIEW
Facilitating Treatment Initiation in Early-Stage Alzheimer Disease is organized by CME Institute of Physicians Postgraduate Press, Inc. (PPP).
Activity opens: 05/27/2022
Activity expires: 06/02/2024
Overview:
Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what, when to better treat your patients with AD from specialists in the field.
Learning Objectives:
• Facilitate prompt treatment initiation for patients who have early-stage AD
Additional details will be posted as soon as information is available.
ACCREDITATION & CREDITS
Accreditation Statement
The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
The CME Institute of Physicians Postgraduate Press, Inc., designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note: The American Nurses Credentialing Center (ANCC) and the American Academy of Physician Assistants (AAPA) accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
To obtain credit for this activity, study the material and complete the CME Posttest and Evaluation.
Available Credit
0.50 AMA PRA Category 1 Credit™
0.50 Participation
TARGET AUDIENCE
PhysicianPhysician AssistantPrimary Care PractitionersNeurologyNeurologistsPsychiatristsNurse PractitionersSPECIALITIES
Neurology
Quick Links